Výsledky vyhledávání - Matthias Pinter
- Zobrazuji výsledky 1 - 20 z 59
- Přejít na další stránku
-
1
-
2
-
3
-
4
-
5
-
6
-
7
-
8
The effects of sorafenib on the portal hypertensive syndrome in patients with liver cirrhosis and hepatocellular carcinoma – a pilot study Autor Matthias Pinter, Wolfgang Sieghart, Thomas Reiberger, Nataliya Rohr‐Udilova, Arnulf Ferlitsch, Markus Peck‐Radosavljevic
Vydáno 2011Artigo -
9
Sorafenib in Unresectable Hepatocellular Carcinoma from Mild to Advanced Stage Liver Cirrhosis Autor Matthias Pinter, Wolfgang Sieghart, Ivo Graziadei, Wolfgang Vogel, A Maieron, Robert Königsberg, Adalbert Weißmann, Gabriela Kornek, Christina Plank, Markus Peck‐Radosavljevic
Vydáno 2009Artigo -
10
Efficacy and Safety of Atezolizumab and Bevacizumab in the Real-World Treatment of Advanced Hepatocellular Carcinoma: Experience from Four Tertiary Centers Autor Vera Himmelsbach, Matthias Pinter, Bernhard Scheiner, Marino Venerito, Friedrich Sinner, Carolin Zimpel, Jens U. Marquardt, Jörg Trojan, Oliver Waidmann, Fabian Finkelmeier
Vydáno 2022Artigo -
11
Carvedilol for primary prophylaxis of variceal bleeding in cirrhotic patients with haemodynamic non-response to propranolol Autor Thomas Reiberger, Gregor Ulbrich, Arnulf Ferlitsch, B.A. Payer, Philipp Schwabl, Matthias Pinter, Birgit Heinisch, Michael Trauner, Ludwig Kramer, Markus Peck‐Radosavljevic
Vydáno 2012Artigo -
12
Systemic inflammation increases across distinct stages of advanced chronic liver disease and correlates with decompensation and mortality Autor Dalila Costa, Benedikt Simbrunner, Mathias Jachs, Lukas Hartl, David Bauer, Rafael Paternostro, Philipp Schwabl, Bernhard Scheiner, Albert Friedrich Stättermayer, Matthias Pinter, Michael Trauner, Mattias Mandorfer, Thomas Reiberger
Vydáno 2020Artigo -
13
Prognostic performance of non-invasive tests for portal hypertension is comparable to that of hepatic venous pressure gradient Autor Mathias Jachs, Lukas Hartl, Benedikt Simbrunner, Georg Semmler, Lorenz Balcar, Benedikt Hofer, Michael Schwarz, David Bauer, Albert Friedrich Stättermayer, Matthias Pinter, Michael Trauner, Thomas Reiberger, Mattias Mandorfer
Vydáno 2024Artigo -
14
A bilateral tumor model identifies transcriptional programs associated with patient response to immune checkpoint blockade Autor Ivy X. Chen, Kathleen Newcomer, Kristen E. Pauken, Vikram R. Juneja, Kamila Naxerova, M. Wu, Matthias Pinter, Debattama R. Sen, Meromit Singer, Arlene H. Sharpe, Rakesh K. Jain
Vydáno 2020Artigo -
15
Study protocol: Fecal Microbiota Transplant combined with Atezolizumab/Bevacizumab in Patients with Hepatocellular Carcinoma who failed to achieve or maintain objective response to... Autor Katharina Pomej, Adrian Frick, Bernhard Scheiner, Lorenz Balcar, Larissa Pajancic, Anton Klotz, Alexander Kreuter, Katharina Lampichler, Katharina Regnat, Kerstin Zinober, Michael Trauner, Dietmar Tamandl, Christoph Gasché, Matthias Pinter
Vydáno 2025Artigo -
16
Association of Platelet Count and Mean Platelet Volume with Overall Survival in Patients with Cirrhosis and Unresectable Hepatocellular Carcinoma Autor Bernhard Scheiner, Martha M. Kirstein, Sabine Popp, Florian Hucke, Simona Bota, Nataliya Rohr‐Udilova, Thomas Reiberger, Christian Müller, Michael Trauner, Markus Peck‐Radosavljevic, Arndt Vogel, Wolfgang Sieghart, Matthias Pinter
Vydáno 2018Artigo -
17
Decreasing von Willebrand Factor Levels Upon Nonselective Beta Blocker Therapy Indicate a Decreased Risk of Further Decompensation, Acute-on-chronic Liver Failure, and Death Autor Mathias Jachs, Lukas Hartl, Benedikt Simbrunner, David Bauer, Rafael Paternostro, Bernhard Scheiner, Philipp Schwabl, Albert Friedrich Stättermayer, Matthias Pinter, Ernst Eigenbauer, Peter Quehenberger, Michael Trauner, Thomas Reiberger, Mattias Mandorfer
Vydáno 2021Artigo -
18
The Sequential Application of Baveno VII Criteria and VITRO Score Improves Diagnosis of Clinically Significant Portal Hypertension Autor Mathias Jachs, Lukas Hartl, Benedikt Simbrunner, David Bauer, Rafael Paternostro, Bernhard Scheiner, Lorenz Balcar, Georg Semmler, Albert Friedrich Stättermayer, Matthias Pinter, Peter Quehenberger, Michael Trauner, Thomas Reiberger, Mattias Mandorfer
Vydáno 2022Artigo -
19
Use of inhibitors of the renin–angiotensin system is associated with longer survival in patients with hepatocellular carcinoma Autor Matthias Pinter, Arndt Weinmann, Marcus‐Alexander Wörns, Florian Hucke, Simona Bota, Jens U. Marquardt, Dan G. Duda, Rakesh K. Jain, Peter R. Galle, Michael Trauner, Markus Peck‐Radosavljevic, Wolfgang Sieghart
Vydáno 2017Artigo -
20
Safety of direct oral anticoagulants in patients with advanced liver disease Autor Georg Semmler, Katharina Pomej, David Bauer, Lorenz Balcar, Benedikt Simbrunner, Teresa Binter, Lukas Hartl, Jeannette Becker, Matthias Pinter, Peter Quehenberger, Michael Trauner, Mattias Mandorfer, Ton Lisman, Thomas Reiberger, Bernhard Scheiner
Vydáno 2021Artigo
Vyhledávací nástroje:
Související témata
Internal medicine
Medicine
Hepatocellular carcinoma
Gastroenterology
Oncology
Cancer
Immunotherapy
Cirrhosis
Chemotherapy
Adverse effect
Bevacizumab
Cohort
Sorafenib
Atezolizumab
Cancer research
Liver disease
Nivolumab
Portal hypertension
Portal venous pressure
Biology
Confidence interval
Immunology
Chronic liver disease
Cardiology
Disease
Pembrolizumab
Biochemistry
Chemistry
Decompensation
Hazard ratio